Towards Healthcare
Nootropics Market Size Anticipates 14.64% CAGR by 2034

Nootropics Market Trends and Unlocking Cognitive Potential

Forecasts suggest that the nootropics market will expand from USD 4.98 billion in 2024 to USD 19.53 billion by 2034, with a CAGR of 14.64% during this period. In 2024, North America led the nootropics market, while Asia Pacific is set for the fastest growth. Capsules/tablets dominated by form, but drinks will grow the quickest. Offline channels led in distribution, while online sales are expected to expand the fastest during the forecast period.

Nootropics Market Size, Benefits, Smart Drugs and Neuroenhancers Boosters

The global nootropics market size reached USD 5.71 billion in 2025 and is expected to be worth USD 19.53 billion by 2034, expanding at a CAGR of 14.64% from 2025 to 2034. Increased consumer expenditure on wellness and healthcare goods is anticipated to support market expansion throughout the projected period.

Nootropics Market Size 2023 - 2034

Unlock Infinite Advantages: Subscribe to Annual Membership

Key Takeaways

  • North America dominated the market with the largest market share in 2024.
  • Asia Pacific is anticipated to grow at the fastest rate in the nootropics market over the forecast period.
  • By form, the capsules/tablets segment led the market in 2024.
  • By form, the drinks segment is predicted to witness the fastest growth in the market over the forecast period.
  • By distribution channel, the offline segment dominated the market in 2024.
  • By distribution channel, the online segment is anticipated to grow at the fastest rate in the nootropics market during the forecast period.

Nootropics Market: Growth and Future Prospects

Nootropics are medicines that are brain supplements and smart drugs that improve cognitive abilities, including memory, creativity, motivation, and general mental performance, which are made up of natural, semisynthetic, or synthetic compounds. With rising interest in comprehensive wellness, there is a greater need for natural and plant-based nootropics. These compounds are suggested because they originate from plants and are consistent with natural, sustainable, and ethical wellness practices. The demand for nootropics has grown as a result of the aging population, the rise in brain disorders like dementia, and other conditions like arthritis. Additionally, these medications are used to treat Parkinson's disease and other age-related and cognitive issues, such as hyperactivity. Thus, the rising prevalence of brain disease is also expected to stimulate industry growth in the future.

  • In February 2025, In The Zone Labs launched an educational campaign to promote the benefits of nootropic supplements and de-aging solutions. By highlighting ingredients like lion’s mane mushrooms, L-theanine, and alpha-GPC, the company aims to tap into the rapidly growing global supplement market, offering consumers insights into cognitive enhancement and mental clarity. With a focus on an underserved audience, In The Zone Labs is poised to expand its reach in the wellness sector.
  • In August 2024, Paradigm Sports partnered with the UK-based Ten Percent Club to educate athletes on the cognitive benefits of nootropics. The collaboration focuses on enhancing mental performance and recovery through nootropic-based supplements, aiming to redefine athlete performance and optimize mental preparation in the sports industry.

How Can AI Revolutionize the Nootropics Market?

By predicting consumer trends, speeding up the discovery of new compounds that increase cognition, and combining ingredients with combinations that most effectively fit individual requirements, AI can improve the nootropics market. It can also optimize the dosage and research and development to ensure consistent quality and safety. AI provides practical, driven methods for improving cognitive function, resulting in more specialized and efficient consumer goods. Customized information and monitoring tools based on AI marketing and education may also help firms better engage their consumers and help them make smarter decisions.

Market Dynamics

Driver

Personalization Trends

One major factor driving the nootropics industry is the move towards customization, which is influencing consumer preferences and product development tactics. As customers want more specific solutions in wellness and health, the idea of personalization has grown in acceptance. More precisely, consumers seek goods that improve, the effects of thoughts, moods, and overall health, emotional and mental states in addition to bodily well-being. The act of altering goods and experiences to suit individual tastes is known as customization. Demand and tendencies towards personalization are driving innovation in the nootropics sector.

Restraint

Lack of Regulations

Lack of regulation is a significant issue in the global nootropics business since different safety and quality requirements for these supplements may result from a lack of uniform regulations. Since most items for improving memory, aging, and cognitive function are supplements rather than pharmaceuticals, they are not held to the same testing criteria that establish their quality and effectiveness. Without regulation, the number of counterfeit goods that endanger consumers' health has increased.

Opportunity

Rising E-Commerce Expansion

The nootropics industry offers a huge chance to grow e-commerce, which will transform nootropic product accessibility, distribution, and marketing. The growing acceptance of internet purchasing and shifting consumer behavior have both contributed to the growth of this trend. The nootropic supplement firm Nootrobox has successfully sold its products directly to consumers through online channels. By using social media advertising and influencer relationships to boost sales and visibility, they have achieved this. Customer reviews and ratings, which are made possible by e-commerce, can also have a big impact on decisions to buy and help firms establish credibility and confidence. Market participants can take advantage of the expanded opportunities brought about by e-commerce as more people look to digital solutions for their health and wellness demands.

Segmental Insights

The Capsules/Tablets Segment Led the Market

The capsules/tablets segment led the nootropics market in 2024. Because of its mobility, ease of usage, and ability to provide precise quantities, capsules have long been the preferred form for the use of nootropics. Additionally, capsules save time and simplify the ingesting process because they don't need to be mixed or measured like liquid or powdered forms do. Individuals who are looking for a quick and easy way to improve their cognitive abilities without having to prepare in advance can find this technique appealing. As a result, capsules will remain the most popular during the forecast period.

Qualia Mind is a nootropic pill supplement made by Neurohacker Collective. This product comes in capsule form and contains substances that are known to enhance mental clarity, attention, and memory, such as alpha-GPC, bacopa monnieri, and L-theanine. In the market for cognitive improvement, it is a top product.

Drinks Segment: Fastest Growing

By form, the drinks segment is predicted to witness the fastest growth in the nootropics market over the forecast period. Liquid nootropics often include cognitive-boosting substances together with other useful components, including vitamins, adaptogens, and organic extracts. Moreover, it is absorbed more quickly than meals and provides an immediate cognitive boost, which is becoming more and more popular. Additionally, adding natural components like ginseng and ashwagandha to nootropic drinks is in line with the public's growing interest in natural remedies, which in turn increases demand for nootropic drinks. These natural ingredients are believed to strengthen immunity, improve mood, and ward off fatigue.

Offline Segment Dominated

In 2024, the offline segment led the nootropics market by distribution channel. Traditional retail facilities such as pharmacies & drugstores, supermarkets, hypermarkets, and convenience stores are still in business and provide customers with easy access to these products in several areas. Customers gain from in-person interactions at these physical locations, where they can make fast purchases, ask knowledgeable staff for advice, and examine items in person. Offline channels sometimes allow nootropic companies to participate in local events, workshops, and seminars to bolster their standing in the health and wellness community. Consequently, during the projection period, offline channels will remain dominant.

Online Segment: Fastest Growing

By distribution channel, the online segment is expected to grow at the fastest rate in the nootropics market during the forecast period. Compared to traditional merchants, online channels are more convenient and save time when it comes to placing orders. Online marketplaces, brand websites, and e-commerce platforms make it easy for customers to investigate, assess, and buy nootropic goods from the convenience of their homes. Online retailers like Amazon, iHerb, and Vitacost, among others, offer a simple buying experience, which is one reason for this rise. Online access to product specifications, user reviews, and educational resources enables customers to make informed decisions.

Regional Insights

Rising Demand Dominated the North America

In 2024, North America captured the largest revenue share and dominated the nootropics market. Nootropics are increasingly gaining popularity due to the rising trend of health and wellness in this area. Due to this trend, consumers are exploring natural and holistic approaches to well-being, and nootropic products derived from natural ingredients align with these changes. Additionally, the growing presence of major competitors in this market, along with their ongoing product introductions, has boosted the local appeal of nootropics and increased their demand over the forecast year.

Increased Prevalence Promotes Asia Pacific

The Asia-Pacific region is expected to experience the fastest growth rate in the nootropics market throughout the forecast period. Increasing awareness of daily nutritional needs, brain health, and changing lifestyle trends have fueled consumer interest in specific medical supplements, such as functional and nootropics, in the Asia Pacific region. Nations such as South Korea and Japan are at the forefront of embracing nootropic medications due to their health-focused cultures and advanced technological settings. The use of natural nootropics is also impacted by conventional herbal remedies and natural treatments. As people struggle to fulfill their nutritional requirements with standard diets, they are increasingly recognizing the importance of additional dietary supplements such as vitamins, minerals, nootropics, and others.

Top Companies in the Nootropics Market

Nootropics Market Companies

Latest Announcement by Industry Leaders

The CEO of BrainBoost Labs, Dr. Emily Roberts, talked about the partnership with CognitivePharm and emphasized their shared dedication to satisfying the rising demand for cutting-edge nootropic products. The collaboration, which brings together more than 40 years of experience, is to hasten the creation of cutting-edge goods that improve mental health and performance.

Recent Developments in the Nootropics Market

  • The first nootropics food lab in Canada was established in January 2025 by Raymond Thomas, a biology professor at Western University. The lab creates brain-boosting meals by fusing Western science with Indigenous dietary expertise. To promote brain health through functional meals, Thomas and his colleagues will develop novel dishes in collaboration with an in-house chef and utilize biochemistry and metabolomics to assess their cognitive effects.
  •  In February 2025, The Scientific Advisory Board and Research Snapshot sections were launched by Nootropics Depot to increase openness and confidence in the supplement sector. The new advisory board will supervise product formulations and study evaluations to guarantee the highest levels of safety and efficacy. It will include specialists in integrative medicine, fitness, plant biology, and ethnobotany.

Segments Covered in the Report

By Form

  • Capsules/Tablets
  • Powder
  • Drinks
  • Others

By Distribution Channel

  • Offline
  • Online

By Region

  • North America
    • US
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
  • Insight Code: 5438
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Last Updated: 26 February 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Shivani Zoting is a healthcare market research expert with 2+ years of experience, specializing in analyzing trends, identifying growth opportunities, and providing actionable insights for businesses across healthcare sectors.

Learn more about Shivani Zoting

Aditi Shivarkar, with 14+ years of healthcare market research experience, ensures the accuracy, clarity, and relevance of reports. Her expertise helps businesses make informed decisions and stay competitive in healthcare sectors.

Learn more about Aditi Shivarkar

Related Reports

FAQ's

Some commonly discussed nootropics include caffeine, L-theanine, racetams (like Piracetam), Bacopa Monnieri, Lions mane mushroom, Ashwagandha, and Ginkgo Biloba.

The most potent cognitive enhancers are usually nootropic substances like nicotine, modafinil, and racetams (like piracetam). These drugs are known to enhance general cognitive function, memory, and attention. Individual effects may differ, though, so prolonged usage should be handled carefully.

National Cancer Institute, National Institutes of Health, MedlinePlus, Centers for Disease Control and Prevention, American Cancer Society, FDA, WHO, GOV.UK.